Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-12-29 00:00:00 ET · period of report 2025-12-22 · accession 0001061983-25-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-29 | 2025-12-22 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +3,177 | 52.2K | +6% | $0 |
| 2025-12-29 | 2025-12-22 | CYTK | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $62.72 | -675 | 53.2K | -1% | -$42.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-22 | A | A | 1,588 | $0.00 | 53,837 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-22 | F | D | 675 | $62.72 | 53,162 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-22 | A | A | 1,589 | $0.00 | 52,249 | D | — | — |